While the time reduction is noteworthy, the real story isn't just Moody's impressive efficiency gains. It's how the company's ...

Consider a rare condition without a defined ICD-10 code. Historically, these patients would be invisible to claims-based studies. But with unstructured data, pharma teams can identify key terms, ...